Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.235 USD | -3.14% | -16.27% | +37.50% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.50% | 405M | |
-3.82% | 102B | |
+1.84% | 96.07B | |
-1.80% | 21.66B | |
-17.61% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.20% | 13.79B | |
-1.15% | 13.33B | |
+18.66% | 10.94B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics : Wedbush Adjusts Mersana Therapeutics' Price Target to $25 From $26, Keeps Outperform Rating